SEPTInvestingStart Free

IKT SCHEDULE 13G/A: SEC filing

Filed with the SEC on · accession 0001875620-26-000017

IKT filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. Sands Capital Life Sciences Pulse Fund II, L.P. and affiliated entities filed a joint filing statement (Exhibit 1) as part of an amended Schedule 13G for Inhibikase Therapeutics, Inc. The filing is a procedural joint acquisition statement under Rule 13d-1(k), with no change in ownership disclosed… The stock moved +0.4% by the first close after the filing.

Summary of the filing

Sands Capital Life Sciences Pulse Fund II, L.P. and affiliated entities filed a joint filing statement (Exhibit 1) as part of an amended Schedule 13G for Inhibikase Therapeutics, Inc. The filing is a procedural joint acquisition statement under Rule 13d-1(k), with no change in ownership disclosed in the exhibit text.

For details, click here →

Key details

Issuer/subject companyInhibikase Therapeutics, Inc.
Reporting holder (filer)Sands Capital Life Sciences Pulse Fund II, L.P.
General partner of reporting holderSands Capital Life Sciences Pulse Fund II-GP, L.P.
General partner of gp entitySands Capital Life Sciences Pulse Fund II-GP, LLC
Affiliated reporting entitySands Capital Alternatives, LLC
General counsel, sands capitalJonathan Goodman
Authorized signatory, sands capital alternatives, llcFrank M. Sands

How IKT stock reacted

Close before

$2.40

Aug 12, 2026

First close after

+0.42%

$2.41

5 trading days

+2.08%

$2.45

Since filing

-37.50%

$1.50

✦ Ask GOAX AI about this filing — what it means for IKT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IKT?

Click here

Frequently asked questions

What did IKT file with the SEC on Aug 13, 2026?

IKT filed a SCHEDULE 13G/A (SEC filing). Sands Capital Life Sciences Pulse Fund II, L.P. and affiliated entities filed a joint filing statement (Exhibit 1) as part of an amended Schedule 13G for Inhibikase Therapeutics, Inc. The filing is a procedural joint acquisition statement under Rule 13d-1(k), with no change in ownership disclosed in the exhibit text.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did IKT stock react to this filing?

IKT closed at $2.40 before the filing and $2.41 on Aug 13, 2026 (+0.42%). Five trading days later: $2.45 (+2.08%).

Other IKT SEC filings

Get alerts when IKT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
IKT overviewIKT analysisIKT newsLatest SEC filings